Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
Catalent, Inc. (CTLT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Maselli Alessandro (President & CEO) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 3,974 shares
@ $0
Sold 1,970 shares
@ $44.51, valued at
$87.7k
Sold 101 shares
@ $45.15, valued at
$4.6k
|
|
| 08/25/2023 |
4
| Gunther Scott (SVP, Quality & Reg. Affairs) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 1,081 shares
@ $0
Sold 269 shares
@ $44.57, valued at
$12k
|
|
| 08/25/2023 |
4
| Grippo Michael J (SVP, Strategy & Corp. Dev.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 1,114 shares
@ $0
Sold 390 shares
@ $44.5, valued at
$17.4k
|
|
| 08/25/2023 |
4
| Gennadios Aristippos (Group Pres. Pharma & Consumer) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 1,590 shares
@ $0
Sold 396 shares
@ $44.49, valued at
$17.6k
|
|
| 08/25/2023 |
4
| Fasman Steven L (EVP & Chief Admin Officer) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 2,226 shares
@ $0
Sold 817 shares
@ $44.65, valued at
$36.5k
|
|
| 08/25/2023 |
4
| Carletti Lorenzo (SVP Global Ops Ph & Cons Hlth) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 457 shares
@ $0
Sold 216 shares
@ $44.71, valued at
$9.7k
|
|
| 08/25/2023 |
4
| Arnold Jonathan (SVP, CCO & Div. Head BioP Del.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 1,590 shares
@ $0
Sold 87 shares
@ $44.87, valued at
$3.9k
|
|
| 08/25/2023 |
4
| Hopson Ricky (Pres. Clinical Dev Supply Div) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 789 shares
@ $0
Sold 276 shares
@ $44.56, valued at
$12.3k
|
|
| 08/25/2023 |
4
| Hawkeswood Thomas W (Pres. Pharma Prod Delivery Div) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 268 shares
@ $0
Sold 147 shares
@ $44.72, valued at
$6.6k
|
|
| 08/25/2023 |
4
| Lickfold Charles (SVP, CIO) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 637 shares
@ $0
Sold 190 shares
@ $44.72, valued at
$8.5k
|
|
| 08/25/2023 |
4
| Hunt Patricia (Pres. Consumer Health Div) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 289 shares
@ $0
Sold 106 shares
@ $44.77, valued at
$4.7k
|
|
| 08/25/2023 |
4
| Pravda Ricardo (Chief Transformation Officer) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 1,081 shares
@ $0
Sold 379 shares
@ $44.47, valued at
$16.9k
|
|
| 08/03/2023 |
4
| Santiago Karen Murphy (VP & Chief Accounting Officer) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 2,342 shares
@ $0
Granted 5,216 options to buy
@ $46.51, valued at
$242.6k
|
|
| 08/03/2023 |
4
| Zayas Ricardo (SVP, Operations, Biologics NA) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 4,435 shares
@ $0
Granted 9,878 options to buy
@ $46.51, valued at
$459.4k
|
|
| 08/03/2023 |
4
| Pravda Ricardo (Chief Transformation Officer) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 47 shares
@ $46.5, valued at
$2.2k
Sold 222 shares
@ $47.78, valued at
$10.6k
Granted 9,783 shares
@ $0 |
|
| 08/03/2023 |
4
| Maselli Alessandro (President & CEO) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 879 shares
@ $46.71, valued at
$41.1k
Sold 606 shares
@ $47.75, valued at
$28.9k
|
|
| 08/03/2023 |
4
| Lickfold Charles (SVP, CIO) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 135 shares
@ $47.9, valued at
$6.5k
Granted 5,322 shares
@ $0
Granted 11,854 options to buy
@ $46.51, valued at
$551.3k
|
|
| 08/03/2023 |
4
| Ferraro Joseph Anthony (SVP, General Counsel, CCO) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 5,145 shares
@ $0
Granted 11,459 options to buy
@ $46.51, valued at
$533k
|
|
| 08/03/2023 |
4
| Hunt Patricia (Pres. Consumer Health Div) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 161 shares
@ $47.95, valued at
$7.7k
Granted 1,952 shares
@ $0
Granted 4,347 options to buy
@ $46.51, valued at
$202.2k
|
|
| 08/03/2023 |
4
| Hopson Ricky (Pres. Clinical Dev Supply Div) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 195 shares
@ $47.86, valued at
$9.3k
Granted 4,790 shares
@ $0
Granted 10,669 options to buy
@ $46.51, valued at
$496.2k
|
|
| 08/03/2023 |
4
| Hawkeswood Thomas W (Pres. Pharma Prod Delivery Div) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 258 shares
@ $47.97, valued at
$12.4k
Granted 2,306 shares
@ $0
Granted 5,137 options to buy
@ $46.51, valued at
$238.9k
|
|
| 08/03/2023 |
4
| Gunther Scott (SVP, Quality & Reg. Affairs) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 190 shares
@ $47.9, valued at
$9.1k
Granted 5,322 shares
@ $0
Granted 11,854 options to buy
@ $46.51, valued at
$551.3k
|
|
| 08/03/2023 |
4
| Grippo Michael J (SVP, Strategy & Corp. Dev.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 35 shares
@ $46.64, valued at
$1.6k
Sold 241 shares
@ $47.88, valued at
$11.5k
Granted 6,209 shares
@ $0
Granted 13,830 options to buy
@ $46.51, valued at
$643.2k
|
|
| 08/03/2023 |
4
| Gennadios Aristippos (Group Pres. Pharma & Consumer) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 61 shares
@ $46.58, valued at
$2.8k
Sold 220 shares
@ $47.87, valued at
$10.5k
Granted 8,870 shares
@ $0
Granted 19,756 options to buy
@ $46.51, valued at
$918.9k
|
|
| 08/03/2023 |
4
| Carletti Lorenzo (SVP Global Ops Ph & Cons Hlth) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 383 shares
@ $47.77, valued at
$18.3k
Granted 3,903 shares
@ $0
Granted 8,693 options to buy
@ $46.51, valued at
$404.3k
|
|
| 08/03/2023 |
4
| Arnold Jonathan (SVP, CCO & Div. Head BioP Del.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 62 shares
@ $47.8, valued at
$3k
|
|
| 08/03/2023 |
4
| Fasman Steven L (EVP & Chief Admin Officer) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 1,113 shares
@ $46.72, valued at
$52k
Sold 524 shares
@ $47.76, valued at
$25k
Granted 11,885 shares
@ $0
Granted 26,473 options to buy
@ $46.51, valued at
$1.2M
|
|
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2023 |
4
| CARROLL J MARTIN (Director) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 555 shares
@ $0 |
|
| 07/07/2023 |
4
| Masanovich Matti (SVP, CFO) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 36,864 shares
@ $0
Granted 81,082 options to buy
@ $44.76, valued at
$3.6M
|
|
| 05/03/2023 |
4
| Boerman Manja (Pres. BioModalities Division) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 1,446 shares
@ $49.86, valued at
$72.1k
|
|
| 05/03/2023 |
4
| Gargiulo Mario (SVP, Ops, Biologics Europe) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 678 shares
@ $49.86, valued at
$33.8k
|
|
| 01/25/2023 |
4
| Hopson Ricky (Pres. Clinical Dev Supply Div) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 643 shares
@ $49.36, valued at
$31.7k
|
|
| 12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|